No Data
No Data
Alpha Cognition Receives Notice of Allowance for Composition-of-Matter Patent for ZUNVEYL for Mild to Moderate Alzheimer's Disease
Express News | Alpha Cognition Inc - Received Indications of Interest From Parties Wanting to Provide Bridge Funding
Express News | Alpha Cognition Inc - Has Chosen to Explore Alternative Strategies
Express News | Alpha Cognition Inc - Decision to Temporarily Delay Its Planned Capital Raise and Uplisting to Nasdaq Capital Market
Alpha Cognition, Inc. On Track to Secure Financing for Continued Growth
Alpha Cognition Announces Financial Results for the Second Quarter and Six Months Ended June 2024 and Provides Corporate Update
No Data